Chlorhexidine (diacetate)


CAS No. : 56-95-1

56-95-1
Price and Availability of CAS No. : 56-95-1
Size Price Stock
100mg $25 In-stock
500mg $50 In-stock
1g $70 In-stock
5g $140 In-stock
10g $196 In-stock
50 g Get quote
100 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-W013699
M.Wt: 625.55
Formula: C26H38Cl2N10O4
Purity: >98 %
Solubility: Ethanol : 55 mg/mL (ultrasonic);H2O : 20 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 56-95-1 :

Chlorhexidine diacetate is a cationic antimicrobial agent that targets microbial cell membranes. It binds to cell membrane phospholipids non-specifically, destroys membrane structure and induces leakage of cell contents. It has broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria. Chlorhexidine diacetate can interfere with membrane permeability, cause protein precipitation and energy metabolism disorders, such as rapid inhibition of microbial growth and induction of cell death (necrosis or apoptosis)[1][2][3]. In Vitro:1. Cell death assay:
Chlorhexidine diacetate (0.000125%-0.016%; 24 h) induced cell death in L929 fibroblasts, inducing a pattern of cell necrosis and/or apoptosis, as well as cell stress. Furthermore, Chlorhexidine diacetate induced apoptosis at lower concentrations and necrosis at higher concentrations, and increased the expression of heat shock protein 70 (a marker of cell stress). Taken together, these findings suggest that CHX may have an adverse effect on the resolution of apical periodontitis[1].
2. Cell viability experiment:
The results of treating canine embryonic fibroblasts and Staphylococcus aureus with chlorhexidine diacetate (0.0005%-0.5%; 30 minutes) showed that concentrations ≥0.013% caused the death of canine embryonic fibroblasts, while concentrations ≤0.006% allowed cell survival; concentrations ≥0.05% killed Staphylococcus aureus, while concentrations ≤0.03% allowed bacterial survival[3].
3. Bacterial survival experiment:
The bactericidal effect of chlorhexidine diacetate (0.0005%-0.5%; 30 minutes) on Staphylococcus aureus was concentration-dependent. Concentrations ≥0.05% could completely kill the bacteria, while concentrations ≤0.03% significantly increased the bacterial survival rate[3].
In Vivo:1. Paw injection toxicity test:
Chlorhexidine diacetate (0.125%-1.0%; subcutaneous injection; single dose) causes toxic effects in the plantar space of the hind paw of Balb/c mice. Concentrations ≥0.5% induces coagulative necrosis of the epidermis, dermis and subcutaneous tissues and neutrophil-dominated inflammatory responses, while concentrations ≤0.25% induces moderate inflammation and interstitial edema[1].
2. Lung inhalation toxicity test:
Chlorhexidine diacetate (0.125%-1%; intratracheal instillation; single dose; 8-week observation) causes collagen fiber deposition and inflammatory cell infiltration in lung tissue in the C57BL/6J mouse model, leading to restrictive ventilation dysfunction. Transcriptome analysis shows that genes related to extracellular matrix deposition and mucus secretion (such as Muc5b and Muc5ac) are upregulated[2].

Your information is safe with us.